RETATRUTIDE - 46 Anuncios
Friday 29 August 2025
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Wednesday 20 August 2025
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Thursday 14 August 2025
Cantidad : 60mg*10via - Precio : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 13 August 2025
Cantidad : 60mg*10via - Precio : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 13 August 2025
Cantidad : 50mg*10via - Precio : USD 550
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 13 August 2025
Cantidad : 40mg*10via - Precio : USD 450
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 13 August 2025
Cantidad : 30mg*10via - Precio : USD 360
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 13 August 2025
Cantidad : 20mg*10via - Precio : USD 300
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 13 August 2025
Cantidad : 15mg*10via - Precio : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 13 August 2025
Cantidad : 10mg*10via - Precio : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 13 August 2025
Cantidad : 5mg*10vial - Precio : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 12 August 2025
Cantidad : 15mg*10via - Precio : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 12 August 2025
Cantidad : 10mg*10via - Precio : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 12 August 2025
Cantidad : 5mg*10vial - Precio : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Saturday 09 August 2025
Cantidad : 15mg*10via - Precio : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Saturday 09 August 2025
Cantidad : 10mg*10via - Precio : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Wednesday 06 August 2025
Cantidad : 5mg*10vial - Precio : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 05 August 2025
Cantidad : 30mg*10via - Precio : USD 360
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 05 August 2025
Cantidad : 5mg*10vial - Precio : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Friday 01 August 2025
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Thursday 31 July 2025
Cantidad : 20mg*10via - Precio : USD 300
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Thursday 31 July 2025
Cantidad : 15mg*10via - Precio : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Thursday 31 July 2025
Cantidad : 10mg*10via - Precio : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Thursday 31 July 2025
Cantidad : 5mg*10vial - Precio : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 29 July 2025
Cantidad : 60mg*10via - Precio : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 29 July 2025
Cantidad : 50mg*10via - Precio : USD 550
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 29 July 2025
Cantidad : 40mg*10via - Precio : USD 450
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 29 July 2025
Cantidad : 30mg*10via - Precio : USD 360
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 29 July 2025
Cantidad : 20mg*10via - Precio : USD 300
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Tuesday 29 July 2025
Cantidad : 15mg*10via - Precio : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
Búsqueda ayuda
- Los resultados contienen todas las palabras, independientemente de la capitalización. Por ejemplo, la búsqueda de Perro Gato devuelve todos los resultados que contengan esas dos palabras.
- Las comillas (") permite búsquedas de frases. En este caso, la búsqueda de "perro gato" devuelve todos los mensajes que contengan la frase exacta, con espacio.
- El signo menos (-) elimina palabras. En este caso, la búsqueda de perro y gato devuelve todos los mensajes que contienen perro pero no gato. Usted puede poner un signo menos (-) delante de una frase entre comillas ("), como perro -"gato siamés".


